coopervision eye delay annual meet coopervision delay annual meet june allow board review recapitalization option meet coopervision report quarter net income million dollar million dlr pretax sale ophthalmic business johnson johnson jnj million dollar cash million dlr posttax charge debt repurchase sale million dollar earlier earn dollar dlr loss discontinue operation sale million dollar company aggressive program investment spend maintain increase market share core business accelerate sale growth hold increase operate income near future coopervision furthermore entire net cash proceed recent sale business employ reduce indebtedness strategic acquisition otherwise employ relation recapitalization company recovery net income hold loss particularly tax income ophthalmic pharmaceutical business sell johnson johnson 
